New diabetes clinical trial: Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

Published on: June 07, 2019 at 07:00PM
Condition:   Type1 Diabetes Mellitus
Interventions:   Drug: empagliflozin;   Device: artificial pancreas
Sponsors:   Samuel Lunenfeld Research Institute, Mount Sinai Hospital;   McGill University Health Center
Not yet recruiting